Henning Hachmann

Title: Henning Hachmann: Innovator in Biomedicine

Introduction

Henning Hachmann is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of biomedicine, particularly in the development of monoclonal antibodies and stabilization processes for biologically active substances. With a total of three patents to his name, Hachmann's work has the potential to impact medical diagnostics and therapeutic applications.

Latest Patents

Hachmann's latest patents include innovative methods for the selective immunological determination of procollagen peptides. His first patent describes a monoclonal antibody specifically directed against an epitope of amino-terminal procollagen peptide (type III), which allows for accurate determination of this peptide in body fluids. The second patent focuses on a process for stabilizing biologically active substances, particularly antibodies, immobilized on a carrier. This process involves contacting the solid phase with a solution containing polyanetholesulfonic acid and/or its salts, enhancing the stability of these substances.

Career Highlights

Hachmann is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical and chemical sectors. His work at Hoechst has allowed him to explore and develop groundbreaking technologies that contribute to advancements in medical science. His expertise in immunology and biochemistry has positioned him as a key figure in his field.

Collaborations

Hachmann has collaborated with notable colleagues such as Guido Simons and Peter Molz. These partnerships have fostered an environment of innovation and have led to the successful development of his patented technologies.

Conclusion

Henning Hachmann's contributions to the field of biomedicine through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical diagnostics and therapeutic solutions.